Your session is about to expire
← Back to Search
N/A
DASH Diet for Heart Failure (DASH-HF Trial)
N/A
Waitlist Available
Led By Francene Steinberg, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Heart Failure diagnosis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up probnp at 6 months
Awards & highlights
DASH-HF Trial Summary
This trial is testing whether the DASH diet can help manage heart failure by looking at different ways the diet affects people.
Who is the study for?
This trial is for heart failure patients who have been on a stable, optimized medical regimen for at least 30 days. It's not suitable for individuals with a BMI under 18.5, those experiencing severe weight loss due to illness (cardiac cachexia), end-stage kidney disease or dialysis, ongoing inflammation, uncontrolled heart rhythm problems or ischemia, or those who've had a heart transplant or have an implanted heart pump.Check my eligibility
What is being tested?
The study is examining the effectiveness of the DASH diet—a dietary approach to stop hypertension—in managing outpatient heart failure. Researchers will use behavioral assessments and clinical tests to measure how well this diet works in improving patient health.See study design
What are the potential side effects?
Since the intervention involves dietary changes rather than medication, side effects may include nutritional imbalances if not properly followed. However, no specific side effects are directly associated with following the DASH diet as it promotes overall healthy eating.
DASH-HF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with heart failure.
DASH-HF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ dietary intake at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~dietary intake at 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood Pressure
Diet score
Dietary intake
Secondary outcome measures
Heart Failure clinical marker
Patient report of HF symptoms
Patient report of eating habit self efficacy
DASH-HF Trial Design
1Treatment groups
Experimental Treatment
Group I: Dietary Intervention ArmExperimental Treatment1 Intervention
Subjects will receive the active intervention of nutrition education and medical nutrition therapy counseling for dietary and behavioral lifestyle changes. The focus will be on DASH diet implementation and adherence for management of heart failure. The subjects will have 4 study visits with a Registered Dietitian over 6 months (visits at 1, 2, 3, and 6 months). Outcome measures will be assessed at baseline, 3 and 6 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DASH diet
2010
Completed Phase 4
~980
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
910 Previous Clinical Trials
4,706,965 Total Patients Enrolled
6 Trials studying Heart Failure
2,564 Patients Enrolled for Heart Failure
American College of CardiologyOTHER
17 Previous Clinical Trials
325,960 Total Patients Enrolled
4 Trials studying Heart Failure
2,650 Patients Enrolled for Heart Failure
Francene Steinberg, PhDPrincipal InvestigatorUniversity of California, Davis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with heart failure.Your body mass index (BMI) is below 18.5.You have had a heart transplant or have a device to help your heart pump.My current treatment for my condition has been stable for at least 30 days.I have irregular heartbeats or heart issues not managed by medication.I have end-stage kidney disease or am on dialysis.I am currently experiencing an acute inflammatory condition.I have significant weight loss due to heart disease.
Research Study Groups:
This trial has the following groups:- Group 1: Dietary Intervention Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current number of participants enrolled in this clinical trial?
"Affirmative. According to the clinicaltrials.gov website, this medical trial is actively seeking individuals for participation. Initially posted on February 1st 2022 and most recently updated on February 9th of the same year, 25 participants from 2 centres need to be enrolled in order for the study to proceed."
Answered by AI
Are participants currently being enrolled for this medical experiment?
"Affirmative. Clinicaltrials.gov documents that this clinical trial has opened its recruitment, which launched on February 1st 2022 and was most recently updated on the 9th of that month. 25 patients are required for enrolment at 2 sites."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger